BioSeek, Inc. And EPA Expand ToxCast(TM) Contract
Published: Jun 30, 2009
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--BioSeek, Inc., a pioneer in the application of predictive human biology to drug discovery, announced today that the United States Environmental Protection Agency (EPA) will utilize BioSeek's BioMAP® Systems technology to profile the biological effects of compounds in a second phase of the agency’s ToxCast™ program. The new program expands upon a successful proof-of-concept phase begun in 2007, after which EPA and independent investigators compared the toxicity profiling data from a wide number of profiling technologies including BioMAP. BioSeek will now generate BioMAP data on an additional set of chemicals selected by EPA in order to assess the potential impact of these compounds on the environment and human health.